1186507-66-3

Basic information

• Product Name: 2-[(1-benzyl-5-bromo-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid
• Synonyms: 2-[(1-benzyl-5-bromo-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid
• CAS NO: 1186507-66-3
• Molecular Weight: 403.275
• Mol File: 1186507-66-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[(1-benzyl-5-bromo-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(1-benzyl-5-bromo-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid(1186507-66-3)
• EPA Substance Registry System: 2-[(1-benzyl-5-bromo-1H-indazol-3-yl)methoxy]-2-methylpropanoic acid(1186507-66-3)

Safety Data

• Hazardous Substances Data: 1186507-66-3(Hazardous Substances Data)

Upstream product

• 130641-38-2 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid 

Relevant articles and documents

NOVEL 1-BENZYL-3-HYDROXYMETHYLINDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 AND P40

The present invention relates to novel 1-benzyl-3-hydroxymethylindazole derivatives according to Formula (I) described in the claims, and to a pharmaceutical composition comprising them, together with a pharmaceutically acceptable vehicle. In addition, the present invention relates to the use of 1-benzyl-3-hydroxymethylindazole derivatives for the preparation of a pharmaceutical composition that is active in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40, and to their use in a method for treating or preventing diseases based on the expression of MCP-1, CX3CR1 and p40.